Literature DB >> 16138943

How to achieve good compliance and adherence with inhalation therapy.

Mathieu Molimard1.   

Abstract

The correct use of inhaler devices is an inclusion criterion for all studies comparing inhaled treatments. However, in real life patients make many errors when inhaling their medication which may negate the benefits observed in clinical trials. A recently published observational study evaluated inhaler handling in 3811 patients for at least 1 month using the Aerolizer, Autohaler, Diskus, pressurised metered dose inhaler (pMDI) or Turbuhaler devices. Inhalation errors were considered critical if they could have substantially affected drug delivery to the lung. The two most common errors made by patients were device-independent errors and included not breathing out before actuation of the device (28.9%) and failure to breath-hold for a few seconds after inhalation (28.3%). These errors were observed in 40%-47% of patients. The number of patients making at least one error with breath-actuated inhalers was high; with less than 50% of patients inhaling correctly. Seventy-six per cent of patients made at least one error with pMDI compared to 49%-55% with breath-actuated inhalers. With respect to device-dependent errors, the pMDI fared worst with 69% of patients exhibiting at least one error, closely followed by the Turbuhaler (32%) and Autohaler (41%). Critical errors were made by only 11%-12% of patients treated with Aerolizer, Autohaler or Diskus compared to 28% and 32% of patients treated with pMDI and Turbuhaler, respectively. Over-estimation of good inhalation by GPs was maximal for Turbuhaler (24%) and lowest for Autohaler and pMDI (6%). Ninety per cent of GPs felt that participation in the study would improve error detection. Compliance may be improved by educating patients and physicians in the correct use of inhaler devices. Inhalers should be easy to use correctly, and have multiple feedback and control mechanisms which would reduce physician over-estimation of a correct inhalation, allow compliance to be monitored, facilitate patient self-education and give reassurance to patients in the real life setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138943     DOI: 10.1185/030079905X61776

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  8 in total

1.  A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.

Authors:  Katayoon Najafizadeh; Hamid Sohrab Pour; Mojtaba Ghadyanee; Masoud Shiehmorteza; Masoud Jamali; Sayeed Majdzadeh
Journal:  Emerg Med J       Date:  2007-05       Impact factor: 2.740

Review 2.  Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting.

Authors:  Mathieu Molimard; Ioannis Kottakis; Juergen Jauernig; Sonja Lederhilger; Ivan Nikolaev
Journal:  Clin Drug Investig       Date:  2021-03-25       Impact factor: 2.859

3.  A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.

Authors:  Marc Miravitlles; Jéssica Montero-Caballero; Frank Richard; Salud Santos; Juan Luis Garcia-Rivero; Francisco Ortega; Xavier Ribera
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-26

Review 4.  Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.

Authors:  Omar Sharif Usmani; Federico Lavorini; Jonathan Marshall; William Christopher Nigel Dunlop; Louise Heron; Emily Farrington; Richard Dekhuijzen
Journal:  Respir Res       Date:  2018-01-16

Review 5.  Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD.

Authors:  Raúl De Simón Gutiérrez; Raúl Piedra Castro
Journal:  Curr Allergy Asthma Rep       Date:  2022-09-10       Impact factor: 4.919

6.  Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols.

Authors:  Winfried Möller; Uwe Schuschnig; Gülnaz Celik; Wolfgang Münzing; Peter Bartenstein; Karl Häussinger; Wolfgang G Kreyling; Martin Knoch; Martin Canis; Sven Becker
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

Review 7.  Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Authors:  Mark L Levy; P N R Dekhuijzen; P J Barnes; M Broeders; C J Corrigan; B L Chawes; L Corbetta; J C Dubus; Th Hausen; F Lavorini; N Roche; J Sanchis; Omar S Usmani; J Viejo; W Vincken; Th Voshaar; G K Crompton; Soren Pedersen
Journal:  NPJ Prim Care Respir Med       Date:  2016-04-21       Impact factor: 2.871

8.  Asthma and COPD Patients' Perception of Appropriate Metered-Dose Inhaler Technique.

Authors:  Wijdan H Ramadan; Aline Sarkis; Sandrine Sarine Aderian; Aline Milane
Journal:  Dose Response       Date:  2020-04-07       Impact factor: 2.658

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.